Decreased mortality and increased side effects in COVID-19 patients treated with IL-6 receptor antagonists: systematic review and meta-analysis
Abstract There is controversy whether IL-6 (receptor) antagonists are beneficial in treating COVID-19 patients. We therefore update our systematic review to answer the following research questions: (1) Do patients hospitalized for COVID-19 treated with IL-6 (receptor) antagonists have lower mortalit...
Guardado en:
Autores principales: | Jishnu Malgie, Jan W. Schoones, Maurice P. Zeegers, Bart G. Pijls |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/86e26ea5d9164fbfa81ea8a0b3825009 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
THE EFFICACY, SIDE-EFFECTS, AND MORTALITY COMPARISON BETWEEN PARACETAMOL AND IBUPROFEN IN PATENT DUCTUS ARTERIOSUS TREATMENT FOR PREMATURE INFANTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Lokot Donna Lubis
Publicado: (2021) -
Severe South American ocular toxoplasmosis is associated with decreased Ifn-γ/Il-17a and increased Il-6/Il-13 intraocular levels.
por: Alejandra de-la-Torre, et al.
Publicado: (2013) -
Antipsychotic-induced extrapyramidal side effects: A systematic review and meta-analysis of observational studies.
por: Tilahun Ali, et al.
Publicado: (2021) -
Dynamical trade-offs arise from antagonistic coevolution and decrease intraspecific diversity
por: Weini Huang, et al.
Publicado: (2017) -
A high-fat diet impairs reproduction by decreasing the IL1β level in mice treated at immature stage
por: Jie Zhang, et al.
Publicado: (2017)